Title:
ＡＫＲ１Ｃ３選択的阻害剤及びその用途
Document Type and Number:
Japanese Patent JP7178075
Kind Code:
B2
Abstract:
To provide a novel, potent and selective AKR1C3 inhibitor and an application thereof.SOLUTION: The present invention provides a novel AKR1C3 inhibitor composed of a 8-hydroxy chromene derivative. The AKR1C3 can be used for e.g. treating castration resistant prostate cancer.SELECTED DRAWING: None
Inventors:
Satoshi Endo
Toshiyuki Matsunaga
Akira Ikari
Naoki Toyooka
Naohiro Fujimoto
Toshiyuki Matsunaga
Akira Ikari
Naoki Toyooka
Naohiro Fujimoto
Application Number:
JP2018055182A
Publication Date:
November 25, 2022
Filing Date:
March 22, 2018
Export Citation:
Assignee:
Universal Corporation Co., Ltd.
International Classes:
A61K31/352; A61K45/00; A61P15/00; A61P35/00; A61P43/00
Domestic Patent References:
| JP2018027897A | ||||
| JP2015020966A |
Foreign References:
| WO2017202817A1 | ||||
| US5648378 |
Other References:
Organic and Biomolecular Chemistry,2015年,Vol.13,pp.7487-7499
Attorney, Agent or Firm:
Kazuhiro Nomura